Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 233 - Carboxylic acid amides
Patents for C07C 233 - Carboxylic acid amides (28,881)
09/2005
09/22/2005WO2005087370A1 C1-symmetric bisphosphine ligands and their use in the asymmetric synthesis of pregabalin
09/22/2005WO2005087215A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/22/2005WO2005004802A3 N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
09/22/2005US20050209455 Bisphosphines as bidentate ligands
09/22/2005US20050209333 Malonamic acids and derivatives thereof as thyroid receptor ligands
09/22/2005US20050209212 2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid; carbapenems derivatives containing a carboxy substituted phenyl group; broad spectrum antibacterial activity; good stability; beta-lactamases inhibitors; improvement over imipenem
09/22/2005US20050209113 Acylation of triethylene tetramine with maleic acid, or maleic anhydride; solution graft polymerization with ethylene or propylene homopolymers, copolymers or terpolymers, polyisobutene, polymethacrylates, polyalkylstyrenes, or partially hydrogenated polybutadiene or polystyrene
09/22/2005US20050208015 Glycerol derivative
09/22/2005CA2570255A1 4-t-butylgabapentin and its synthesis
09/22/2005CA2560111A1 Aminophenylpropanoic acid derivative
09/22/2005CA2559086A1 C1-symmetric bisphosphine ligands and their use in the asymmetric synthesis of pregabalin
09/22/2005CA2558249A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/21/2005EP1577289A1 Non-glycosylated/-glycosidic/-peptidic small molecule selectin inhibitors for the treament of inflammatory disorders
09/21/2005EP1577281A1 Process for preparing combinatorial libraries
09/21/2005EP1575922A1 Biphenyl derivatives and their use as fungicides
09/21/2005EP1575911A2 Biaromatic compounds which activate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions
09/21/2005EP1575902A1 Vermin-repellant compositions and compounds
09/21/2005EP1575495A2 Compounds and methods
09/21/2005EP1444550B1 Polycarbocyclic derivatives for modification of resist, optical and etch resistance properties
09/21/2005CN1671654A Gelling agents
09/21/2005CN1671650A Crystalline beta2 adrenergic receptor agonist
09/21/2005CN1671649A Process for preparing nateglinide and intermediates thereof
09/21/2005CN1670009A Propynyl or dienyl biaromatic compounds
09/21/2005CN1669650A Process for preparing acrylonitrile hydrated copper base catalyst by coprecipitation method
09/21/2005CN1219759C Intermediate for preparing substitated biphenyl oxazoline compounds
09/21/2005CN1219750C Industrial production of capsaicin with seed and skin of red hot pepper as material
09/20/2005US6946576 amidation; reacting an amine and an ester in the presence of a silylating agent as catalyst under mild conditions
09/20/2005US6946569 high stereoselectivity; mannitol and tartaric acid starting materials, hydrogenation of ketones, imines, and olefins; 1,2((2,2',5,5'-tetramethyl, 3,3',4,4'-tetrahydroxy) bisphospholane)benzene.
09/20/2005US6946560 Ligands for metals and improved metal-catalyzed processes based thereon
09/20/2005US6946532 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
09/20/2005US6946491 such as 3-[(4-(2-fluorobenzyloxy)phenyl)-methylthio]propionic acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
09/20/2005US6946462 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
09/20/2005US6946060 From aqueous solution containing acetic acid; distillation
09/20/2005US6946025 Process for preparing tetra-amide compounds
09/20/2005CA2211668C Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing the same
09/15/2005WO2005085189A2 Analogues of congo red and evaluation of their anti-prion activity
09/15/2005WO2005085180A1 Method of amidocarbonylation reaction
09/15/2005WO2005084658A1 Derivatives of actarit and their therapeutic use
09/15/2005WO2004029019A8 Compounds for the treatment of alzheimer’s disease
09/15/2005US20050203226 Nucleating agents incorporated within; injection molding; films, fibers, profiles, pipes, bottles, tanks, containers
09/15/2005US20050203112 Bicyclic amides
09/15/2005US20050203096 Compounds to treat Alzheimer's disease
09/15/2005DE102004009835A1 New 4-heterocyclyl-benzamide derivatives, useful as antithrombotic agents for treating or preventing e.g. deep vein thrombosis or reocclusion after angioplasty, are inhibitors of factor Xa and other serine proteases
09/15/2005CA2555890A1 Heteroalkyl-substituted biphenyl-4-carboxylic acid arylamide analogues
09/14/2005EP1574498A1 Process for the synthesis of substituted alpha-aminoindan derivatives
09/14/2005EP1574495A1 Adamantane derivatives
09/14/2005EP1574494A1 Adamantane derivative
09/14/2005EP1572645A2 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex
09/14/2005EP1572629A1 COMPOUNDS WHICH MODULATE PPARϝ TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
09/14/2005EP1572625A1 Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives as pharmaceutical agents
09/14/2005EP1572624A1 Method for producing light coloured polyalkylene glycol diethyl ether of fatty acid alcanolamine
09/14/2005EP1392643B1 Trisubstituted-n- (1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors
09/14/2005CN1668670A Weatherable polycarbonate comprising N, N'-oxanilide structural units, its preparation method, and products made therefrom
09/14/2005CN1668578A Flavourant compounds
09/14/2005CN1218932C Method for synthesizing 5-butyrylamino-2-hydroxy hypnone
09/09/2005WO2005082956A1 Styrene derivative, styrene polymer, photosensitive resin composition, and method for forming pattern
09/09/2005WO2005082839A1 Amide compound
09/09/2005WO2005082838A1 New process for the synthesis of substituted alpha -aminoindan derivatives
09/09/2005WO2004074232A8 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
09/08/2005US20050197511 Reacting an acid and an amine; apoptosis; carbamate, and N-phenethyl-2-phenylacetamide
09/08/2005US20050197392 O-desmethylvenlafaxine and methods of preparing and using the same
09/08/2005US20050197387 E2,E4,Z8-undecatrienoic acid and ester and carboxamide derivatives thereof, organoleptic uses thereof and processes for preparing same
09/08/2005US20050197362 Preventives/remedies for urinary disturbance
09/07/2005EP1571140A1 C-substituted cyclohexylmethylamine derivatives
09/07/2005EP1569896A1 Tetrahydro-naphthalene derivatives
09/07/2005CN1665780A Tricyclic steroid hormone nuclear receptor modulators
09/07/2005CN1665574A Purification of N, N-dimethylacetamide
09/07/2005CN1663944A Process for preparing acetamides compounds
09/07/2005CN1663478A Application of bamboo extractive in heat processing food as acrylamide suppressor
09/07/2005CN1663477A Method for using bamboo leaf extract as acrylamide suppressor for heat processing food
09/07/2005CN1217931C Spirocyclic phenyl keto-enols as pesticides and herbicides
09/07/2005CN1217921C Recovery method of heavily polluted substance produced during production of ADC foaming agent
09/07/2005CN1217920C Compounds to treat Alzheimer disease
09/07/2005CN1217903C Substituted biphenyl oxazoline
09/06/2005US6939986 From 1,2-epoxides; useful as inhibitors of viral or bacterial neuraminidases
09/06/2005US6939985 covalently coupling organic compounds by reacting an aromatic ring compound having a halogen or halogen-like substituent at a coupling position with a diboron derivative in the presence of a Group VIII metal catalyst and a base
09/06/2005CA2217479C Derivatives of phenoxyethylamine having a high affinity for 5-ht1a receptor, their preparation procedure, their application as medications and pharmaceutical compounds containing them
09/06/2005CA2067690C Amino acid derivatives
09/01/2005WO2005080367A1 Ep2 receptor agonists
09/01/2005WO2005080340A1 Alpha-(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents
09/01/2005WO2005080316A2 Modulators of cannabinoid receptors
09/01/2005WO2005079774A2 Management of ophthalmologic disorders, including macular degeneration
09/01/2005WO2005079541A2 Terephthalamide peptidomimetic compounds and methods
09/01/2005WO2005068403A3 Method for selective reduction of aromatic compounds
09/01/2005WO2005060647A3 Prodrugs of selective androgen receptor modulators and methods of use thereof
09/01/2005US20050192457 Process for the carbonylation of ethylenically or acetylenically unsaturated compounds
09/01/2005US20050192316 Aryl aniline beta2 adrenergic receptor agonists
09/01/2005CA2556940A1 Modulator
09/01/2005CA2556447A1 Terephthalamide peptidomimetic compounds and methods
09/01/2005CA2555814A1 Alpha-(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents
09/01/2005CA2555261A1 Management of ophthalmologic disorders, including macular degeneration
08/2005
08/31/2005EP1568686A1 n-alkylaminated secondary paraphenylendiamine, which is ortho- and/or meta-substituted, dying composition comprising this paraphenylendiamine, methods based on this composition and uses
08/31/2005EP1568685A1 Aminoadamantane derivatives as therapeutic agents
08/31/2005EP1568683A2 Secondary, N-alkylaminated para-phenylenediamines, compositions for dyeing keratinic fibres containing them, processes using this compositions and uses thereof
08/31/2005EP1568682A1 Secondary N-fluoroalkyl-para-phenylenediamines, dye compositions containing them, processes and uses
08/31/2005EP1483276B1 Ferrocenyl ligands and the use thereof in catalysis
08/31/2005EP1095020B1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them
08/31/2005EP0989973B1 Chalcones having antiproliferative activity
08/31/2005CN1662636A Use of transition metal complexes with nitrogen-containing polydentate ligands as a bleaching catalyst and bleaching agent composition
08/31/2005CN1662559A Polymeric photoinitiators
1 ... 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 ... 289